![Oncogenes and Cancer Cells - Biology Encyclopedia - body, function, human, system, different, chromosomes, DNA, organs, blood Oncogenes and Cancer Cells - Biology Encyclopedia - body, function, human, system, different, chromosomes, DNA, organs, blood](https://www.biologyreference.com/images/biol_03_img0324.jpg)
Oncogenes and Cancer Cells - Biology Encyclopedia - body, function, human, system, different, chromosomes, DNA, organs, blood
![CML (chronic myeloid leukemia) is a cancer that affects bone marrow and blood. The diagnosis of CML is confirmed by presence of Philadelphia chromosome on cytogenetics or FISH or by detecting bcr-abl CML (chronic myeloid leukemia) is a cancer that affects bone marrow and blood. The diagnosis of CML is confirmed by presence of Philadelphia chromosome on cytogenetics or FISH or by detecting bcr-abl](https://bizimages.withfloats.com/actual/5977647b93c0f60ad011f010.jpg)
CML (chronic myeloid leukemia) is a cancer that affects bone marrow and blood. The diagnosis of CML is confirmed by presence of Philadelphia chromosome on cytogenetics or FISH or by detecting bcr-abl
![Nilotinib is an Orally Active Bcr-Abl Tyrosine Kinase Inhibitor for CML Research - Network of Cancer Research Nilotinib is an Orally Active Bcr-Abl Tyrosine Kinase Inhibitor for CML Research - Network of Cancer Research](https://www.cancer-research-network.com/wp-content/uploads/2023/11/Nilotinib-is-an-Orally-Available-Bcr-Abl-Tyrosine-Kinase-Inhibitor-for-CML-Research-20231129.jpg)
Nilotinib is an Orally Active Bcr-Abl Tyrosine Kinase Inhibitor for CML Research - Network of Cancer Research
![ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells - ScienceDirect ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721013504-fx1.jpg)
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells - ScienceDirect
![Zack Pemberton-Whiteley (he/him) on X: "What is #CML? What is BCR-ABL? #CMLHZ18 #leukaemia #leukemia #SpotLeukaemia #cancer https://t.co/DcuyD0tMSo" / X Zack Pemberton-Whiteley (he/him) on X: "What is #CML? What is BCR-ABL? #CMLHZ18 #leukaemia #leukemia #SpotLeukaemia #cancer https://t.co/DcuyD0tMSo" / X](https://pbs.twimg.com/media/DcViBcPVQAAvoxY.jpg:large)
Zack Pemberton-Whiteley (he/him) on X: "What is #CML? What is BCR-ABL? #CMLHZ18 #leukaemia #leukemia #SpotLeukaemia #cancer https://t.co/DcuyD0tMSo" / X
![c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells - ScienceDirect c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124715007305-fx1.jpg)
c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells - ScienceDirect
![TUMORIGENIC SIGNALING BY BCR-ABL KINASE. BCR-ABL kinase enables the cancer cells to evade apoptosis through Ras-MAPK pathway and PI3K-AKT survival pathway. TUMORIGENIC SIGNALING BY BCR-ABL KINASE. BCR-ABL kinase enables the cancer cells to evade apoptosis through Ras-MAPK pathway and PI3K-AKT survival pathway.](https://www.researchgate.net/publication/256597754/figure/fig2/AS:669255544619015@1536574364702/TUMORIGENIC-SIGNALING-BY-BCR-ABL-KINASE-BCR-ABL-kinase-enables-the-cancer-cells-to-evade.png)
TUMORIGENIC SIGNALING BY BCR-ABL KINASE. BCR-ABL kinase enables the cancer cells to evade apoptosis through Ras-MAPK pathway and PI3K-AKT survival pathway.
![IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells](https://pub.mdpi-res.com/ijms/ijms-18-00537/article_deploy/html/images/ijms-18-00537-ag.png?1569242802)